Article Text

Download PDFPDF
Intracranial ependymoma in an adult patient with multiple primary malignancies
  1. Shu Yan Thong1,
  2. Benjamin Chua2,
  3. Craig Winter3 and
  4. Manasi Jiwrajka3
  1. 1 Queensland Health, Brisbane, Queensland, Australia
  2. 2 Department of Radiation Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
  3. 3 Kenneth Jamieson Department of Neurosurgery, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
  1. Correspondence to Dr Shu Yan Thong; t1shuyan{at}


The incidence of multiple primary malignancies (MPM) is increasing, and therefore, it has become highly important for clinicians to consider the concept of MPM when treating oncology patients. In this case report, we follow the clinical course of a patient diagnosed with a new intracranial lesion, an ependymoma, on a background of MPM. We explore the barriers implicating the delay in her diagnosis, dissect the challenges in managing her disease and emphasise the importance of social determinants in optimising her care.

  • Global Health
  • CNS cancer
  • Radiotherapy
  • Neurosurgery
  • Neurooncology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors SYT oversaw the project by obtaining consent from the patient, writing the first draft, redrafting and finalising the document. BC and CW supervised the project by reviewing the document. MJ initiated the project by outlining the plan and assisting in several edits of the case report.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.